Angiogenesis inhibitors and their delivery systems

descriptionPublicationkeyboard_double_arrow_right Article 01 Feb 1983 English Publisher:Springer Science and Business Media LLCJournal:Applied Biochemistry and Biotechnology, volume 8, pages 9-24 (issn: 0273-2289, eissn: 1559-0291,

Copyright policy )

Authors: R, Langer; J, Murray;

doi: 10.1007/bf02798344

pmid: 6206793

Angiogenesis inhibitors and their delivery systems

- Summary
- Subjects
- Metrics

Abstract

The extensive vascularity of solid tumors has been recognized for over 100 yr (1). However, only in the past 15 yr has the importance of this phenomenon been appreciated and only in the past 6 yr has the possibility of chemical interference been apparent. In this article, we review the emerging field of tumor vascularization inhibitors.

Related Organizations

Massachusetts Institute of Technology
United States
Children's Hospital & Medical Center
United States
Boston Children's Hospital
United States

Keywords

Neovascularization, Pathologic, Eye Neoplasms, Proteins, Angiogenesis Inhibitors, Corneal Diseases, Cornea, Molecular Weight, Mice, Cartilage, Neoplasms, Animals, Humans, Biological Assay, Rabbits, Melanoma

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	42
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%